Carter's Inc. (CRI) — Fair Value Analysis

Base-case fair value (P50): $45.84 · Current price: $43.35 · Verdict: Fairly Valued

The Verdict on CRI

Based on our Monte Carlo simulations, CARTERS INC (CRI) is currently Fairly Valued. While CRI's current price of $43.35 is slightly below our median fair value (P50) of $45.84, the implied +5.7% upside is not substantial enough to warrant an "undervalued" rating. Our analysis indicates that CRI trades closely to its intrinsic value, with market pricing reflecting the company's current operational health and future prospects as modeled across thousands of scenarios. Investors considering CRI should recognize its near-equilibrium valuation rather than significant mispricing.

How CRI stacks up against peers

CRI maintains an average quality tier relative to its sector peers, signifying a balanced operational and financial health profile. This average quality assessment, derived from various fundamental factors, aligns with its "Fairly Valued" verdict. The Monte Carlo simulations incorporate the company's inherent strengths and weaknesses, concluding that the market price of $43.35 adequately discounts these factors. For a stock with an average quality tier, an +5.7% gap to our $45.84 fair value suggests that its risk-reward profile is broadly in line with its intrinsic potential, limiting immediate arbitrage opportunities based purely on valuation.

What this means for investors

For investors, CRI's "Fairly Valued" status, with its $43.35 trading at a modest +5.7% below our $45.84 median fair value, indicates that the stock is unlikely to offer significant immediate appreciation from a valuation perspective. Given its average quality tier, CRI presents a balanced investment proposition rather than a compelling deep-value or growth play. While a slight +5.7% buffer exists, it suggests that market expectations are largely priced in. To explore the full spectrum of potential outcomes for CRI, including specific bear-case and bull-case scenarios modeled by FairCurve's Monte Carlo simulations, sign up for a free account to track CRI's fair value as new fundamentals are released.

Frequently Asked Questions

Is CRI overvalued or undervalued right now?

CRI is currently Fairly Valued. Our median fair value (P50) is $45.84, while the current market price is $43.35.

What is the bear case and bull case for CRI?

The full Monte Carlo distribution, including our bear (P10) and bull (P90) target prices, along with the probability of upside scenarios, is available with a free FairCurve account. We do not provide specific dollar values here.

How does FairCurve calculate CRI's fair value?

FairCurve calculates CRI's fair value using Monte Carlo simulations, running thousands of forward-looking scenarios to determine a probabilistic range of intrinsic values rather than a single fixed estimate.

How can I track CRI's fair value as it changes?

You can add CRI to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuations whenever new earnings or significant company fundamentals are released.